ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

New Staff Proposals For Comprehensive Center Recognition Considered By NCAB

January 19, 1979

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993

DCPC Board To hear To Hear Concept for Contract to Develop Program For Heavy Smokers

January 11, 1985

UC Davis Coordinates Asian American Network

September 27, 2002